skip to content »

Neurology

Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Jeffrey Scott Bishop, M.S., M.P.A.S., P.A.-C.

Instructor of Neurology

Clinical Service Area

Neurology

Specialty

Alzheimer's Disease
Memory Disorders

Board Certification

National Commission on Certification of Physician Assistants

Clinic Appointments

713-798-4734

Consult

713-798-4734

Graduate School

M.S., University of Houston, Texas
M.P.A.S., University of Texas, Medical Branch at Galveston, Texas

Clinic Location

Baylor Neurology
The Medical Building
1977 Butler Blvd., Suite E5.101
Houston, Texas 77030

Contact Information

Jeffrey Scott Bishop, M.S., M.P.A.S., P.A.-C.
Department of Neurology
Baylor College of Medicine
1977 Butler Blvd., Suite E5.101
Houston, Texas 77030

Tel: 713-798-7374
Fax: 713-798-5326
Email:

Journal Publications (Selected out of 11)

  • Li D, Ronson B, Guo M, Liu S, Bishop JS, Van Echo DA, et al. Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer. Cancer Res. 2002;62(14):4023-8. [View journal article]
  • Li D, Shugert E, Guo M, Bishop JS, O'Malley BW, Jr. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127(11):1319-24. [View journal article]
  • Li D, Zeiders JW, Liu S, Guo M, Xu Y, Bishop JS, et al. Combination nonviral cytokine gene therapy for head and neck cancer. Laryngoscope. 2001;111(5):815-20. [View journal article]
  • Bishop JS, Thull NM, Matar M, Quezada A, Munger WE, Batten TL, et al. Antitumoral effect of a nonviral interleukin-2 gene therapy is enhanced by combination with 5-fluorouracil. Cancer Gene Ther. 2000;7(8):1165-71. [View journal article]
  • Mendiratta SK, Quezada A, Matar M, Thull NM, Bishop JS, Nordstrom JL, et al. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma. Hum Gene Ther. 2000;11(13):1851-62. [View journal article]
  • Blezinger P, Yin G, Xie L, Wang J, Matar M, Bishop JS, et al. Intravenous delivery of an endostatin gene complexed in cationic lipid inhibits systemic angiogenesis and tumor growth in murine models. Angiogenesis. 1999;3(3):205-10. [View journal article]
  • Li D, Jiang W, Bishop JS, Ralston R, O'Malley BW, Jr. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer. Clin Cancer Res. 1999;5(6):1551-6. [View journal article]
  • Coleman M, Muller S, Quezada A, Mendiratta SK, Wang J, Thull NM, et al. Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response. Hum Gene Ther. 1998;9(15):2223-30. [View journal article]
  • Bishop JS, Guy-Caffey JK, Ojwang JO, Smith SR, Hogan ME, Cossum PA, et al. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide. J Biol Chem. 1996;271(10):5698-703. [View journal article]
  • Guy-Caffey JK, Bodepudi V, Bishop JS, Jayaraman K, Chaudhary N. Novel polyaminolipids enhance the cellular uptake of oligonucleotides. J Biol Chem. 1995;270(52):31391-6. [View journal article]

Book Chapters and Other Publications

  • Chaudhary N, Bishop JS, Jayaraman K, Guy-Caffey JK. Improved structural design and cellular uptake of GT-rich triplex-forming oligonucleotides. In: Akhtar S, editor. Delivery strategies for antisense nucleic acids. Boca Raton, FL: CRC Press; 1995.

E-mail this page to a friend